1 minggu yang lalu
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Get Free Report) has been fixed an mean standing of "Moderate Buy" by nan thirteen ratings firms that are covering nan stock, Marketbeat Ratings reports. One investigation expert has rated nan banal pinch a clasp proposal and 12 have…
This communicative appeared connected marketbeat.com, 2024-10-26 09:10:11.
English (US) · 
Indonesian (ID) ·